External Evaluation of the Roll Back Malaria (RBM) Partnership
The Roll Back Malaria (RBM) Partnership was launched in 1998 by the World Health Organization (WHO), the United Nations Development Program (UNDP), the United Nations Children’s Fund (UNICEF) and The World Bank. The RBM Partnership — which includes constituencies from malaria endemic countries, development organizations, OECD donor countries, foundations, NGOs, private sector, research and academia — has become the leading global initiative for mobilizing action and resources, forging consensus and coordinating efforts in the worldwide fight against malaria.
CGHD will conduct an external evaluation of RBM through selective document review, stakeholder interviews, country visits, and electronic surveys of RBM partners. Site visits will be conducted in Cameroon, Senegal, Kenya, and Zimbabwe. Specific evaluation objectives include:
- Assess the extent to which the RBM partnership has contributed/ progressed towards milestones set out in the Global Malaria Action Plan (GMAP) and identify factors that have facilitated or hindered progress.
- Assess strengths and weaknesses in RBM structures and processes to achieve those milestones & objectives and determine the extent to which structures are optimized.
- Examine and describe the relevance and effectiveness of the RBM Partnership’s response to the prior evaluation (2004-08).
- Identify challenges and gaps faced by the RBM partnership in the later years of the GMAP and, more broadly, in the post-2015 environment and propose strategies for addressing those.
|Principal Investigator||Jonathon Simon|
|BU Co-Investigators||Kojo Yeboah-Antwi, Malcolm Bryant, Monita Baba-Djara, Bram Brooks|
|Country(ies)||Cameroon, Senegal, Kenya, Zimbabwe|
|Dates of Research||2013|